TNF and rheumatoid arthritis: Based on these observations, we assumed that currently available treatments for RA (including most common methotrexate treatment, anti-TNF treatment and other disease modifying anti-rheumatic drugs, DMARDs) are only palliative and influence the symptoms of inflammation rather than disease-developing pathways.